3. BALANCE SHEET COMPONENTS (Tables)

6 Months Ended

Oct. 31, 2013

Notes to Financial Statements

Inventory

	October 31, 2013		April 30, 2013
Raw materials	$	28,779	$	28,779
Finished goods		69,206		70,425
	$	97,985	$	99,204

Other current assets

	October 31, 2013		April 30, 2013
R&D materials	$	106,573	$	159,892
Other		106,054		7,090
Deferred cost of sales		35,000		-
Dermacyte samples		3,428		3,428
	$	251,055	$	170,410

Property Plant and Equipment

	October 31, 2013			April 30, 2013
Laboratory equipment	$	768,252		$	768,252
Computer equipment and software		134,311			135,697
Office furniture and fixtures		130,192			130,192
		1,032,755			1,034,141
Less: Accumulated depreciation and amortization		(872,543	)		(828,752	)
	$	160,212		$	205,389

Accrued Liabilities

	October 31, 2013		April 30, 2013
Operating costs	$	103,666	$	19,865
Employee related		92,060		66,632
Deferred revenue		52,285		185,068
Restructuring liability		43,728		43,728
Government grant expenses		26,704		-
Convertible note interest payable		4,000		59,583
Accrued settlement costs		-		500,000
	$	322,443	$	874,876

Other liabilities

	October 31, 2013			April 30, 2013
Net non-cancelable operating lease obligation	$	76,524		$	98,388
Less: current portion		(43,728	)		(43,728	)
Long-term portion of net non-cancelable operating lease obligation	$	32,796		$	54,660